Influence of Body Mass Index on Measured and Calculated Androgen Parameters in Adult Women with Hirsutism and PCOS

Abstract

There is growing evidence that obesity in women lead to a more severe form of hyperandrogenism and other endocrine abnormalities which may have some health implications later in life. Obese females are at higher risk for metabolic syndrome due to severe hyperandrogenemia. Calculated values for free testosterone are equivalent to those obtained by equilibrium dialysis, which is one of the reference measurement procedures (RMP) for estimation of free testosterone and may be capable of replacing values estimated using RMP's. For adult women correlations of body mass index (BMI) with calculated free (cFT) and bioavailable testosterone (cBT) are still rare, while these data are reported for peripubertal and adolescent girls. In this study we aimed to investigate the association between BMI and different androgen parameters (including calculated free and bioavailable testosterone, free androgen index, and sex hormone-binding globulin [SHBG]) in adult women with Hirsutism and with PCOS. In hirsute women with BMI ≥25 kg/m2 measured total testosterone (TT) was significantly higher, SHBG was significantly lower and the calculated androgen parameter (FAI, cFT and cBT) were significantly higher compared to women with BMI <25 kg/m2. In PCOS women with BMI ≥25 kg/m2 TT was significantly higher, SHBG was significantly lower and the calculated androgen parameter (FAI, cFT and cBT) were also significantly higher compared to women with BMI <25 kg/m2. In both the Hirsutism and PCOS-group there was a positive correlation between BMI and TT, cFT, and cBT, while BMI was negatively correlated with SHBG. In summary, in adult women with Hirsutism and PCOS obesity is associated with increased levels of TT and decreased levels of SHBG resulting in significant elevated calculated free and bioavailable testosterone levels. Obesity might lead to a more severe form of hyperandrogenism with elevated calculated free and bioavailable testosterone in the study population.

Body Mass Index - free testosterone - Hirsutism - Hyperandrogenemia - SHBG

References

• 1 Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2005;  90 ((4)) 1929-1935
• 2 Archer JS, Chang RJ. Hirsutism and acne in polycystic ovary syndrome.  Best Pract Res Clin Obstet Gynecol. 2004;  18 737-754
• 3 Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal.  Fertil Steril. 2005;  83 1343-1346
• 4 Azziz R, Carmina E, Sawaya ME. Idiopathic Hirsutism.  Endocr Rev. 2000;  21 ((4)) 347-362
• 5 Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC. et al . Androgen excess in women: experience with over 1000 consecutive patients.  J Clin Endocrinol Metab. 2004;  89 453-462
• 6 Bjorntorp P. The regulation of adipose tissue distribution in humans.  Int J Obes Relat Metab Disord. 1996;  20 291-302
• 7 Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.  J Clin Endocrinol Metab. 2006;  91 492-497
• 8 Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids.  Am J Physiol. 1998;  274 1645-1652
• 9 Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. PCOS/Troglitazone Study Group . Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2006;  91 ((1)) 48-53
• 10 Elmlinger MW, Kuhnel W, Wormstall H, Doller PC. Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age.  Clin Lab. 2005;  51 625-632
• 11 Gambineri A, Pelusi C, Genghini S, Morselli-Labate AM, Cacciari M, Pagotto U, Pasquali R. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.  Clin Endocrinol (Oxf). 2004;  60 241-249
• 12 Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.  Best Pract Res Clin Endocrinol Metab. 2006;  20 193-205
• 13 Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.  Best Pract Res Clin Obstet Gynecol. 2004;  18 671-683
• 14 Hatch R, Rosenfield Rl, Moon HK, Tredway D. Hirsutism: implications, etiology and management.  Am J Obstet Gynecol. 1981;  140 815-830
• 15 Ibanez L, De Zegher F. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.  J Clin Endocrinol Metab. 2003;  88 4720-4724
• 16 Ibanez L, Valls C, Ferrer A, Ong K, Dunger DB, De Zegher F. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.  J Clin Endocrinol Metab. 2002;  87 2870-2874
• 17 Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know?.  J Clin Endocrinol Metab. 2004;  89 2569-2575
• 18 Korhonen S, Hippelainen M, Vanhala M, Heinonen S, Niskanen L. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study.  Fertil Steril. 2003;  79 1327-1334
• 19 Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).  Clin Endocrinol (Oxf). 2005;  62 644-649
• 20 Li X, Lin JF. Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome [Abstract].  Zhonghua Yi Xue Za Zhi. 2005;  85 3266-3271
• 21 Ly PL, Handelsman DJ. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays.  Eur J Endocrinol. 2005;  152 471-478
• 22 Mathur RS, Moody LO, Landgrebbe S, Williamson HO. Plasma androgens and sex hormone binding globulin in the evaluation of hirsute patients.  Fertil Steril. 1981;  35 29-37
• 23 Marin P, Lonn L, Andersson B, Oden B, Olbe L, Bengtsson BA, Bjorntorp P. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone.  J Clin Endocrinol Metab. 1996;  81 1018-1022
• 24 McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, Foster CM, Marshall JC. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.  J Clin Endocrinol Metab. 2006;  91 1714-1722
• 25 Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.  Endokrynol Pol. 2005;  56 883-890
• 26 Mizutani T, Nishikawa Y, Adachi H, Enomoto T, Ikegami H, Kurachi H, Nomura T, Miyake A. Identification of estrogen receptor in human adipose tissue and adipocytes.  J Clin Endocrinol Metab. 1994;  78 950-954
• 27 Mueller A, Cupisti S, Binder H, Hoffmann I, Beckmann MW, Dittrich R. The role of albumin in the calculation of free and bioavailable testosterone in women with hyperandrogenemia.  In Vivo. 2006a;  20 403-407
• 28 Mueller A, Dittrich R, Cupisti S, Beckmann MW, Binder H. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.  Exp Clin Endocrinol Diabetes. 2006b;  114 182-187
• 29 O'Brien SN, Welter BH, Mantzke KA, Price TM. Identification of progesterone receptor in human subcutaneous adipose tissue.  J Clin Endocrinol Metab. 1998;  83 509-513
• 30 Price TM, O'Brien SN. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification.  J Clin Endocrinol Metab. 1993;  77 1041-1045
• 31 Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long term health risk related to polycystic ovary syndrome (PCOS).  Hum Reprod. 2004;  19 1-7
• 32 Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long term health risk related to polycystic ovary syndrome (PCOS).  Fertil Steril. 2004;  81 19-25
• 33 Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R. The prevalence of androgen excess among patients with minimal unwanted hair growth.  Am J Obstet Gynecol. 2004;  191 759-767
• 34 Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S. et al . Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis.  Int J Impot Res. 2005;  23 1-5
• 35 Vague J, Meignen JM, Negrin JF. Effects of testosterone and estrogens on deltoid and trochanter adipocytes in two cases of transsexualism.  Horm Metab Res. 1984;  16 380-381
• 36 van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Insulin, androgen, and gonadotropin concentrations, body mass index, and waist to hip ratio in the first years after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea.  J Clin Endocrinol Metab. 2000;  85 1394-1400
• 37 Vanky E, Kjotrod S, Salvesen KA, Romundstad P, Moen MH, Carlsen SM. Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS.  Acta Obstet Gynecol Scand. 2004;  83 482-486
• 38 Vermeulen A, Verdonck L, Kaufmann JM. A Critical evaluation of simple methods for the estimation of free testosterone in serum.  J Clin Endocrinol Metab. 1999;  84 3666-3672
• 39 Wabitsch M, Hauner H, Heinze E, Bockmann A, Benz R, Mayer H, Teller W. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction.  J Clin Endocrinol Metab. 1995;  80 3469-3475
• 40 Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents.  N Engl J Med. 2004;  350 2362-2374

Correspondence